Atlassian to Release Q2 FY2026 Results on Feb. 5 With Webcast
Atlassian will release Q2 FY2026 results on Feb 5, 2026 after market close, covering the period ended Dec 31, 2025. A conference call and live webcast will be held Feb 5 at 2:00 P.M. PT to discuss results and a shareholder letter will be posted online.
1. Earnings Release Schedule
Atlassian has confirmed it will publish its financial results for the second quarter of fiscal year 2026, covering the period ended December 31, 2025, following market close on Thursday, February 5, 2026. This precise timing gives investors a clear timeline to prepare for any adjustments to their portfolios. By announcing the release date nearly a month in advance, Atlassian ensures market participants have ample time to review its prior guidance and analyst estimates before the company’s updated performance metrics become public.
2. Webcast and Investor Access
On the same day as the earnings release, Atlassian will host a live conference call at 2:00 P.M. Pacific Time (5:00 P.M. Eastern Time), accessible via webcast on its Investor Relations website. A replay of the call will also be available for on-demand listening. In conjunction with the press release, Atlassian plans to post a detailed shareholder letter outlining year-over-year product adoption trends, regional revenue breakdowns, and updates on its AI-driven system of work. This level of transparency supports analysts’ efforts to refine their revenue and margin forecasts ahead of the call.
3. Strategic Position and Investor Implications
Atlassian’s collaboration portfolio serves over 300,000 customers worldwide, including more than 80% of the Fortune 500. High-profile clients such as NASA, Rivian and Deutsche Bank rely on its software for software development and enterprise service management, underscoring its entrenched market position. Investors should watch for commentary on subscription renewal rates, enterprise deal velocity, and any metrics tied to Atlassian’s AI initiatives. Given the company’s history of consistent subscription revenue growth and expanding average contract values, even modest beats or misses in these areas can trigger significant stock movements post-announcement.